Jaguar Animal Net Income From Continuing Ops Over Time
JAGX Stock | USD 1.23 0.24 24.24% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Jaguar Animal Performance and Jaguar Animal Correlation. Jaguar |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jaguar Animal. If investors know Jaguar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jaguar Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 20.2 | Revenue Per Share 11.616 | Quarterly Revenue Growth 0.017 | Return On Assets (0.35) | Return On Equity (2.91) |
The market value of Jaguar Animal Health is measured differently than its book value, which is the value of Jaguar that is recorded on the company's balance sheet. Investors also form their own opinion of Jaguar Animal's value that differs from its market value or its book value, called intrinsic value, which is Jaguar Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jaguar Animal's market value can be influenced by many factors that don't directly affect Jaguar Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jaguar Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Jaguar Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jaguar Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Jaguar Animal Health and related stocks such as Onconova Therapeutics, Ibio Inc, and GeoVax Labs Net Income From Continuing Ops Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBIO | (6.2 M) | (6.2 M) | (6.2 M) | (3.7 M) | (6.6 M) | (10.7 M) | (16.1 M) | (16.1 M) | (17.6 M) | (16.4 M) | (23.2 M) | (50.3 M) | (29.3 M) | (15.4 M) | (16.2 M) |
GOVX | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (2.7 M) | (3.3 M) | (2.2 M) | (2.6 M) | (2.4 M) | (3 M) | (18.6 M) | (14 M) | (23.8 M) | (22.6 M) |
OCGN | (32 M) | (32 M) | (32 M) | (32 M) | (32 M) | (32 M) | (16.2 M) | (26.4 M) | (8.6 M) | (20.2 M) | (21.8 M) | (58.4 M) | (81.4 M) | (63.1 M) | (59.9 M) |
ZURA | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (60.6 M) | (63.6 M) |
ZVSA | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (12.7 M) | (8.1 M) | (14 M) | (89.6 M) | (85.1 M) |
TNXP | (3.5 M) | (3.5 M) | (9.5 M) | (10.9 M) | (27.6 M) | (48.1 M) | (38.8 M) | (21.1 M) | (26.1 M) | (28.6 M) | (50.5 M) | (92.3 M) | (110.2 M) | (121 M) | (115 M) |
PHIO | (20.9 M) | (20.9 M) | (20.9 M) | (20.9 M) | (8.8 M) | (10.2 M) | (9 M) | (12.5 M) | (7.4 M) | (8.9 M) | (8.8 M) | (13.3 M) | (11.5 M) | (11.7 M) | (12.2 M) |
SONN | (5.3 M) | (5.3 M) | (5.3 M) | (5.7 M) | (5.7 M) | (14.5 M) | (7.2 M) | (7.2 M) | (7.2 M) | (17.4 M) | (25 M) | (29.7 M) | (18.8 M) | (17.4 M) | (18.3 M) |
ATNF | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (25.4 M) | (10.9 M) | (20.3 M) | (38.7 M) | (40.5 M) | (42.5 M) |
CDIO | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (605.2 K) | (620.4 K) | (4.7 M) | (9.4 M) | (8.9 M) |
VXRT | (7.5 M) | (7.5 M) | (8.7 M) | (11 M) | (19.1 M) | (25.4 M) | (29.4 M) | (9.6 M) | (18 M) | (18.6 M) | (32.2 M) | (70.5 M) | (107.8 M) | (82.5 M) | (78.3 M) |
Jaguar Animal Health and related stocks such as Onconova Therapeutics, Ibio Inc, and GeoVax Labs Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
Jaguar Animal Health | JAGX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
Location | California; U.S.A |
Exchange | NASDAQ Exchange |
USD 1.23
Additional Tools for Jaguar Stock Analysis
When running Jaguar Animal's price analysis, check to measure Jaguar Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jaguar Animal is operating at the current time. Most of Jaguar Animal's value examination focuses on studying past and present price action to predict the probability of Jaguar Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jaguar Animal's price. Additionally, you may evaluate how the addition of Jaguar Animal to your portfolios can decrease your overall portfolio volatility.